Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Despite their common use as an empirical combination therapy for the better part of a decade, there has been a recent association between combination therapy with vancomycin and piperacillin-tazobactam and high rates of acute kidney injury (AKI). The reasons for this increased association are unclea...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Antimicrob Agents Chemother
Κύριοι συγγραφείς: Karino, Shigehiko, Kaye, Keith S., Navalkele, Bhagyashri, Nishan, Bakht, Salim, Madiha, Solanki, Shantanu, Pervaiz, Amina, Tashtoush, Nader, Shaikh, Hamadullah, Koppula, Sunitha, Martin, Emily T., Mynatt, Ryan P., Murray, Kyle P., Rybak, Michael J., Pogue, Jason M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology 2016
Θέματα:
Clinical Therapeutics
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879358/
https://ncbi.nlm.nih.gov/pubmed/27067325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03011-15
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια